- Home
- TNON vs NAOV Comparison
TNON vs NAOV Comparison
Compare TNON & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- NAOV
- Stock Information
- Founded
- TNON 2012
- NAOV 2003
- Country
- TNON United States
- NAOV United States
- Employees
- TNON N/A
- NAOV N/A
- Industry
- TNON Medical Specialities
- NAOV Industrial Specialties
- Sector
- TNON Health Care
- NAOV Health Care
- Exchange
- TNON Nasdaq
- NAOV Nasdaq
- Market Cap
- TNON 3.2M
- NAOV 3.1M
- IPO Year
- TNON 2022
- NAOV N/A
- Fundamental
- Price
- TNON $1.47
- NAOV $2.56
- Analyst Decision
- TNON Strong Buy
- NAOV
- Analyst Count
- TNON 2
- NAOV 0
- Target Price
- TNON $16.00
- NAOV N/A
- AVG Volume (30 Days)
- TNON 21.4M
- NAOV 2.3M
- Earning Date
- TNON 05-13-2025
- NAOV 05-14-2025
- Dividend Yield
- TNON N/A
- NAOV N/A
- EPS Growth
- TNON N/A
- NAOV N/A
- EPS
- TNON N/A
- NAOV N/A
- Revenue
- TNON $3,277,000.00
- NAOV $2,558,000.00
- Revenue This Year
- TNON $118.16
- NAOV N/A
- Revenue Next Year
- TNON $7.40
- NAOV N/A
- P/E Ratio
- TNON N/A
- NAOV N/A
- Revenue Growth
- TNON 11.92
- NAOV 227.79
- 52 Week Low
- TNON $0.91
- NAOV $1.92
- 52 Week High
- TNON $15.79
- NAOV $13.97
- Technical
- Relative Strength Index (RSI)
- TNON 47.64
- NAOV 36.41
- Support Level
- TNON $2.01
- NAOV $2.90
- Resistance Level
- TNON $3.26
- NAOV $4.69
- Average True Range (ATR)
- TNON 0.50
- NAOV 0.66
- MACD
- TNON 0.03
- NAOV -0.04
- Stochastic Oscillator
- TNON 11.34
- NAOV 18.93
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.